Erratum to: Acyclovir resistance in herpes simplex virus type I encephalitis: a case report (Journal of NeuroVirology, (2017), 23, 2, (335-337), 10.1007/s13365-016-0489-5);Acyclovir resistance in herpes simplex virus type I encephalitis: a case report

Journal of NeuroVirology

Volumn 23, Issue 2, 2017, Pages 335-337

  Bergmann, M ^a   Beer, R ^a   Kofler, M ^a   Helbok, R ^a   Pfausler, B ^a   Schmutzhard, E ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Acyclovir resistance; Encephalitis; Foscarnet; Herpes simplex virus type I

Indexed keywords

ACICLOVIR; DNA POLYMERASE; FOSCARNET; THYMIDINE KINASE; ANTIVIRUS AGENT;

ADULT; ANTIVIRAL THERAPY; APHASIA; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; DIARRHEA; DRUG DOSE INCREASE; FEMALE; FEVER; GENE SEQUENCE; HEADACHE; HERPES SIMPLEX ENCEPHALITIS; HERPES SIMPLEX VIRUS 1; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LUMBAR PUNCTURE; MIDDLE AGED; MOLECULAR BIOLOGY; NEUROIMAGING; NEUROREHABILITATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PLEOCYTOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; TEMPORAL LOBE; VIRUS RESISTANCE; VOMITING; ANTIVIRAL RESISTANCE; COMPLICATION; DIAGNOSTIC IMAGING; DISEASE EXACERBATION; DRUG EFFECTS; DRUG SUBSTITUTION; GENETICS; HERPES SIMPLEX; HUMAN ALPHAHERPESVIRUS 1; LEUKOCYTOSIS; PATHOGENICITY; VIROLOGY;

ACYCLOVIR; ANTIVIRAL AGENTS; DISEASE PROGRESSION; DRUG RESISTANCE, VIRAL; DRUG SUBSTITUTION; ENCEPHALITIS, HERPES SIMPLEX; FEMALE; FOSCARNET; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS; LEUKOCYTOSIS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; TEMPORAL LOBE;

EID: 84992702590     PISSN: 13550284     EISSN: 15382443     Source Type: Journal    
DOI: 10.1007/s13365-017-0541-0     Document Type: Erratum

References (15)

1. Andrei G, Snoeck R (2013) Herpes simplex virus drug-resistance: new mutations and insights. Curr Opin Infect Dis 26:551–560
2. Burns WH, Saral R, Santos GW, Laskin OL, Lietman PS, McLaren C, Barry DW (1982) Isolation and characterisation of resistant Herpes simplex virus after acyclovir therapy. Lancet 1:421–423
3. Christophers J, Clayton J, Craske J, Ward R, Collins P, Trowbridge M, Darby G (1998) Survey of resistance of herpes simplex virus to acyclovir in northwest England. Antimicrob Agents Chemother 42:868–872
4. Crumpacker CS, Schnipper LE, Marlowe SI, Kowalsky PN, Hershey BJ, Levin MJ (1982) Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir. N Engl J Med 306:343–346
5. Danve-Szatanek C, Aymard M, Thouvenot D, Morfin F, Agius G, Bertin I, Billaudel S, Chanzy B, Coste-Burel M, Finkielsztejn L, Fleury H, Hadou T, Henquell C, Lafeuille H, Lafon ME, Le FA, Legrand MC, Maille L, Mengelle C, Morand P, Morinet F, Nicand E, Omar S, Picard B, Pozzetto B, Puel J, Raoult D, Scieux C, Segondy M, Seigneurin JM, Teyssou R, Zandotti C (2004) Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up. J Clin Microbiol 42:242–249
6. Fife KH, Crumpacker CS, Mertz GJ, Hill EL, Boone GS (1994) Recurrence and resistance patterns of herpes simplex virus following cessation of > or =6 years of chronic suppression with acyclovir. Acyclovir Study Group. J Infect Dis 169:1338–1341
7. Gateley A, Gander RM, Johnson PC, Kit S, Otsuka H, Kohl S (1990) Herpes simplex virus type 2 meningoencephalitis resistant to acyclovir in a patient with AIDS. J Infect Dis 161:711–715
8. Joshi AY, Iyer VN, Hagan JB, St Sauver JL, Boyce TG (2009) Incidence and temporal trends of primary immunodeficiency: a population-based cohort study. Mayo Clin Proc 84:16–22
9. Morfin F, Bilger K, Boucher A, Thiebaut A, Najioullah F, Bleyzac N, Raus N, Bosshard S, Aymard M, Michallet M, Thouvenot D (2004) HSV excretion after bone marrow transplantation: a 4-year survey. J Clin Virol 30:341–345
10. Piret J, Boivin G (2011) Resistence of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management. Antimicrob Agents Chemother 55:459–472
11. Safrin S, Crumpacker C, Chatis P (1991) A controlled trial comparing foscarnet with vidarabine for acyclovir resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. N Engl J Med 325:551–555
12. Schulte EC, Sauerbrei A, Hoffmann D, Zimmer C, Hemmer B, Muhlau M (2010) Acyclovir resistance in herpes simplex encephalitis. Ann Neurol 67:830–833
13. Scott HJ, Prichard MN (2014) Current and future therapies for therapies for herpes simplex virus infections: mechanism of action and drug resistance. Curr Opinion Virol 8:54–61
14. Sibrack CD, Gutman LT, Wilfert CM, McLaren C, St Clair MH, Keller PM, Barry DW (1982) Pathogenicity of acyclovir-resistant herpes simplex virus type 1 from an immunodeficient child. J Infect Dis 146:673–682
15. Stranska R, Schuurman R, Nienhuis E, Goedegebuure IW, Polman M, Weel JF, Wertheim-Van Dillen PM, Berkhout RJ, van Loon AM (2005) Survey of acyclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization. J Clin Virol 32:7–18